Testing effectiveness (Phase 2)Ended earlyNCT03477903
What this trial is testing
TAK-954 in Critically Ill Participants With Enteral Feeding Intolerance (EFI)
Who this might be right for
Critical IllnessEnteral NutritionEnteral Feeding Intolerance
Millennium Pharmaceuticals, Inc. 1